Dubai Chamber: UAE medical tourism hit AED 12.1 billion in 2018

Dubai Chamber of Commerce and Industry put UAE medical tourism sales at AED 12.1 billion (about $3.3 billion) in 2018, a 5.5% year-on-year increase that gives hospital owners and CFOs a benchmark for inbound patient revenue.

The number matters because medical tourism touches specialist capacity, digital booking and patient hospitality budgets. Dubai providers answer to the Dubai Health Authority (DHA), Abu Dhabi and Al Ain providers answer to the Department of Health Abu Dhabi (DOH), and Northern Emirates operators answer to the Ministry of Health and Prevention (MOHAP).

What the 2018 number tells operators

The Dubai Chamber analysis, citing Euromonitor International and Fitch Solutions, said UAE health expenditure reached an estimated AED 50.3 billion in 2018, up 5.4% from 2017. Medical tourism was a commercial line for large private hospitals, with enough scale to affect service-line planning and capital allocation.

For CEOs and CFOs, the first decision is where to compete. Dubai Chamber identified orthopaedics, sports medicine, dermatology and skin care, dentistry and fertility treatment among the top specialties for medical tourism in Dubai. Those elective and semi-elective lines depend on price transparency, surgeon reputation, recovery logistics and fast second opinions.

• AED 12.1 billion: UAE medical tourism sales in 2018.
• 5.5%: year-on-year growth in medical tourism sales.
• AED 50.3 billion: estimated UAE health expenditure in 2018.
• 154 hospitals: UAE hospital count in 2018, up from 107 in 2013.

Dubai and Abu Dhabi built the front doors

DHA put medical tourism into a formal channel through Dubai Health Experience (DXH), the online platform that lets patients review packages and book treatment in Dubai. In Abu Dhabi, DOH and the Department of Culture and Tourism Abu Dhabi launched a medical tourism e-portal covering facilities and medical services in the emirate. Both portals moved patient acquisition into regulator-visible digital funnels.

"The medical tourism sector has been fuelled with technology which is bridging the distance."
Taher Shams, managing director, Zulekha Healthcare Group

That technology shift has operating consequences. COOs need multilingual coordinators, pre-arrival clinical review, documented consent, recovery planning and complaint escalation paths. CIOs need patient portals, secure document exchange and CRM workflows that can handle overseas leads under DHA, DOH or MOHAP licensing expectations.

The gap between visits and revenue

DHA figures reported by international medical travel analysts showed 337,011 international medical tourists in Dubai in 2018. The same period was associated with about AED 1.16 billion in Dubai medical tourist expenditure, while the wider UAE sales figure was AED 12.1 billion. Operators should treat the figures as planning inputs because definitions can differ by source, emirate and inclusion of related spending.

The market also had a policy target. Dubai was pursuing more than 500,000 medical tourists by 2020, while Dubai Chamber projected UAE medical tourism sales could reach AED 19.5 billion by 2023. Those forecasts were made before Covid-19 altered international travel patterns, but the 2018 baseline remains useful for board discussions about elective-care investment.

The concrete takeaway for executives is the AED 12.1 billion baseline. Private groups should track overseas lead source, clinical specialty, average bill size, payer mix, cancellation rate and complication follow-up. Operators that can pair 2018-level demand signals with current outcomes data will have a stronger case for capital, consultants and insurer partnerships in 2026.